Bionaturis is one of the candidates to the well-regarded European Small and Midcap Awards that recognizes and gives more visibility to small and medium size enterprises listing on different European financial markets. In this way it was announced yesterday by the president of Spanish Stock Markets (BME in Spanish), Antonio Zoido, during the MedCap Forum.

In this second edition, Bionaturis competes in the “Rising Star” category, that includes those companies with a market capitalization of up to 50 million. This category awards emerging businesses with clearly demonstrated potential for future growth and healthy increase in share prices.

Bionaturis, listing on the MAB since January 2012, has just fulfilled a capital increase of 3 million euros with 76% oversubscription , has increased its sales 96% in 2013 and it is developing its internationalization plan.

Victor Infante, Bionaturis’ CEO, explains that the nomination to these European awards “supports our business model, that is betting on innovation as driving force and is in the springboard of our international expansion. It provides us more confidence to achieve our goals”.

All nominees will be reviewed by a pre-selection committee, and the 16 companies that best meet the eligibility criteria will be shortlisted. An independent jury composed of members of the financial community, journalists and academia will scrutinizes this shortlist to select this year’s winning companies that most exemplify the many advantages of being a publicly listed company. Last year, two of the winners of these international awards were Spanish Carbures and Gowex. The UK satellite company Veripos was the winner into the “Rising Star” category.